Reaxys: Shaping the future of research and innovation

India's pharmaceutical sector has emerged as a global leader in research and innovation, driven by a combination of a robust scientific and technological base, growing government support, strong domestic market, and cost-competitive manufacturing. National Pharmaceutical Policy aligned with Vision 2047 encompasses five key pillars: Fostering Global Pharmaceutical Leadership, Promoting Self-Reliance, Advancing Health Equity and accessibility, Enhancing Regulatory Efficiency in the Indian Pharmaceutical Sector, and Attracting investments. Having evolved into a vibrant sector, India now ranks third globally in pharmaceutical production by volume and 14th by value. Nevertheless, there are certain business growth challenges like steering market dynamics, pricing pressure and sustainability, innovation and value addition, regulatory compliance, and import dependency. To mitigate some of those challenges, an exhaustive chemistry database with competitive intelligence and novelty search use case is key to making informed decisions for novel research and innovation. Reaxys is the largest chemical database, combining over a billion chemistry and bioactivity data points with AI to support innovation in drug discovery and chemical R&D. Objectives of the webinar “Reaxys: Shaping the future of research and innovation” is to address key needs and demonstrate crucial insights for best R&D outcome and achieve business goals.